Taeyoung Kyong | Medical Discoveries | Research Excellence Award

Published on by Scientist Day

Prof. Taeyoung Kyong | Medical Discoveries | Research Excellence Award

Yonsei University College of Medicine | South Korea

Professor Taeyoung Kyong is a distinguished hospitalist and academic at Yonsei University College of Medicine, specializing in internal medicine and diabetes care. His work focuses on hospitalist-led care models that enhance glycemic control, patient safety, and care transitions in inpatient settings. He has led and contributed to impactful clinical research, published extensively in indexed journals, and served as a reviewer for international medical journals. Through collaborations with leading hospitals and medical technology firms, he integrates digital health and AI-driven monitoring into clinical practice, advancing evidence-based hospital medicine and improving outcomes for patients with chronic diseases.
View Orcid Profile

Featured Publications

Ahsan Khan | Biomedical Engineering | Research Excellence Award

Published on by Scientist Day

Dr. Ahsan Khan | Biomedical Engineering | Research Excellence Award

Dr. Ahsan Khan | Tongji University | China

Dr. Ahsan Riaz Khan is an accomplished researcher specializing in chemical engineering, environmental sciences, corrosion science, surface engineering, and biomaterials. He holds advanced academic qualifications in Chemical Engineering and Environmental Sciences, complemented by strong interdisciplinary training across materials development, environmental health, and biomedical applications. He is currently serving as a Postdoctoral Researcher at the School of Medicine, Tongji University, Shanghai, where he contributes to cutting-edge research on biomaterials, corrosion-resistant surfaces, biocompatibility, drug-release systems, and in-vivo/in-vitro implant evaluations. Dr. Khan’s research expertise spans the development of novel, sustainable, and cost-effective coating materials; surface modification of metals and alloys; tribology; anticorrosion technology; adhesion engineering; electrochemical methods; and advanced techniques in cell culture, toxicity analysis, and immunohistochemistry. His interdisciplinary background enables him to work at the intersection of engineering, materials science, medicine, and environmental sustainability. He has published 28 peer-reviewed research papers, contributing significantly to high-impact journals in materials science, corrosion protection, biomaterials, environmental pollution, electrochemistry, and regenerative medicine. His publications have received over 330 citations with an H-index above 10, reflecting strong academic influence and global research engagement. His work includes notable contributions to magnesium alloys, smart scaffolds, hybrid biomaterials, environmental risk assessments, supercapacitive materials, and psychological health investigations. Dr. Khan has earned multiple academic honors, including innovation awards, competitive scholarships, excellence certificates, and internship recognitions. He has participated in a wide range of international conferences, workshops, and training programs in environmental management, materials engineering, GIS, chemical engineering, and waste management. Skilled in a broad array of analytical and characterization techniques—such as SEM, TEM, XPS, XRD, TGA, ICP-OES, GC-MS, Raman spectroscopy, and electrochemical workstations—Dr. Khan combines technical depth with strong research leadership. Fluent in English, Urdu, and conversational Chinese (HSK-3), he remains committed to advancing global research in materials innovation, corrosion engineering, environmental sustainability, and biomedical technology.

Profile: Google Scholar

Featured Publications

Khan, A. R., Grewal, N. S., Zhou, C., Yuan, K., Zhang, H. J., & Jun, Z. Recent advances in biodegradable metals for implant applications: Exploring in vivo and in vitro responses. Results in Engineering, 20, 101526.

Zafar, Z., Mehmood, M. S., Ahamad, M. I., Chudhary, A., Abbas, N., Khan, A. R., … Trend analysis of the decadal variations of water bodies and land use/land cover through MODIS imagery: An in-depth study from Gilgit-Baltistan, Pakistan. Water Supply, 21(2), 927–940.

Rehman, A. U., Shah, M. Z., Ali, A., Zhao, T., Shah, R., Ullah, I., Bilal, H., Khan, A. R., … Thermochemical heat storage ability of ZnSO₄·7H₂O as potential long-term heat storage material. International Journal of Energy Research, 45(3), 4746–4754.

Khan, M., Tiehu, L., Hussain, A., Raza, A., Zada, A., Alei, D., Khan, A. R., Ali, R., … Physiochemical evaluations, mechanical attenuations and thermal stability of graphene nanosheets and functionalized nanodiamonds loaded pitch-derived carbon foam composites. Diamond and Related Materials, 126, 109077.

Khan, Z. U., Razzaq, A., Khan, A., Rehman, N. U., Khan, H., Khan, T., Khan, A. U., … Physicochemical characterizations and pharmacokinetic evaluation of pentazocine solid lipid nanoparticles against inflammatory pain model. Pharmaceutics, 14(2), 409.

Sylvia Mangani | Medical Discoveries | Best Researcher Award

Published on by Scientist Day

Ms. Sylvia Mangani | Medical Discoveries | Best Researcher Award

Ms. Sylvia Mangani | University of Patras | Greece

Sylvia Mangani is a biochemist–biotechnologist and PhD candidate in Biochemistry at the University of Patras, whose research centers on cancer biology, particularly the influence of the extracellular matrix on tumor growth and regulation through 3D cell culture systems. Her academic journey combines strong foundations in biochemistry and biotechnology (BSc, MSc) with advanced experimental and analytical expertise. Her work integrates a broad range of molecular and cellular biology techniques, including quantitative PCR, Western blotting, immunofluorescence, functional assays, and RNA sequencing, complemented by bioinformatics analysis for gene expression and signaling pathway interpretation. Her research has significantly contributed to understanding how 3D cellular microenvironments influence cancer progression, focusing on breast cancer models. She has authored 12 peer-reviewed publications in recognized international journals, with her work cited over 55 times according to Google Scholar, reflecting growing recognition within the scientific community. Her contributions have also supported award-winning synthetic biology initiatives under the iGEM program and have been presented at national and international scientific conferences. She has established productive collaborations with prominent research institutions in Greece and abroad. Notably, she completed a funded Erasmus+ research placement at the University Hospital of Münster, Germany, under the supervision of Prof. Martin Götte, where she engaged in experimental oncology projects exploring cancer cell behavior and matrix interactions. She has also collaborated with the National and Kapodistrian University of Athens on biochemical and molecular analyses within the Laboratory of Biochemistry, Biotechnology, and Molecular Analysis. A member of the Hellenic Society of Biochemistry and Molecular Biology (HSBMB), she actively contributes to the advancement of biochemical and cancer research in Greece and Europe. Her ongoing studies aim to deepen the understanding of tumor–matrix dynamics in breast cancer, offering new insights for therapeutic innovation and cancer model development, positioning her among emerging researchers in molecular oncology.

Profiles: Orcid | Google Scholar | LinkedIn | Research Gate

Featured Publications 

Mangani, S., Piperigkou, Z., Mangani, S., Koletsis, N. E., Koutsakis, C., Mastronikolis, N. S., Franchi, M., & Karamanos, N. K. (2025, August). Principal mechanisms of extracellular matrix‐mediated cell–cell communication in physiological and tumor microenvironments. The FEBS Journal. https://doi.org/10.1111/febs.70207

Mangani, S., Vetoulas, M., Mineschou, K., Spanopoulos, K., Vivanco, M. d. M., Piperigkou, Z., & Karamanos, N. K. (2025, July 15). Design and applications of extracellular matrix scaffolds in tissue engineering and regeneration. Cells, 14(14), 1076. https://doi.org/10.3390/cells14141076

Franchi, M., Masola, V., Onisto, M., Franchi, L., Mangani, S., Zolota, V., Piperigkou, Z., & Karamanos, N. K. (2025, July 7). Ultrastructural changes of the peri-tumoral collagen fibers and fibrils array in different stages of mammary cancer progression. Cells, 14(13), 1037. https://doi.org/10.3390/cells14131037

Karamanos, N. K., Piperigkou, Z., Gourdoupi, C., Mangani, S., & Vivanco, M. d. M. (2025, June 1). Extracellular matrix matters: Matrix-based bioscaffolds in advancing translational cancer research and targeted therapy. American Journal of Physiology-Cell Physiology, 328(6), C1235–C1251. https://doi.org/10.1152/ajpcell.00050.2025

Ciampelli, C., Mangani, S., Nieddu, G., Formato, M., Ioannou, P., Kremmydas, S., Karamanos, N., & Lepedda, A. J. (2025, March). Effects of acidic polysaccharide-enriched extracts from Holothuria tubulosa on two- and three-dimensional invasive breast cancer cell models. Biology, 14(4), 334. https://doi.org/10.3390/biology14040334

Mangani, S., Kremmydas, S., & Karamanos, N. K. (2025, March). Mimicking the complexity of solid tumors: How spheroids could advance cancer preclinical transformative approaches. Cancers, 17(7), 1161. https://doi.org/10.3390/cancers17071161

Saravanan Periasamy | Biotechnology Awards | Best Academic Researcher Award

Published on by Scientist Day

Dr. Saravanan Periasamy | Biotechnology Awards | Best Academic Researcher Award

Dr. Saravanan Periasamy | Rajalakshmi Engineering College Autonomous Chennai India | India

Dr. Saravanan Periasamy is a leading researcher in the field of biofilm science and biotechnology. He serves as an Associate Professor at the Centre of Excellence in Biofilms, Rajalakshmi Engineering College, Chennai. His research focuses on microbial biofilms, exopolysaccharide characterization, and antibiofilm therapeutics. He has completed a prestigious DST-SERB-funded project with impactful scientific outcomes. Dr. Saravanan has published over 30 research papers in reputed SCI and Scopus-indexed journals. He has also contributed five book chapters with international publishers, including CRC Press. His editorial contributions include guest editing for Frontiers in Cellular and Infection Microbiology and Frontiers in Pharmacology. He actively reviews manuscripts for major publishers such as Elsevier, Springer, and Taylor & Francis. Dr. Saravanan’s research excellence is reflected in his 4,474 citations and h-index of 19. He continues to advance innovations in microbial biotechnology through impactful research and academic leadership.

Profile: Google Scholar

Featured Publications

Kolenbrander, P. E., Palmer, R. J., Jr., Periasamy, S., & Jakubovics, N. S. (2010). Oral multispecies biofilm development and the key role of cell–cell distance. Nature Reviews Microbiology, 8(7), 471–480. https://doi.org/10.1038/nrmicro2381

Periasamy, S., Joo, H. S., Duong, A. C., Bach, T. H. L., Tan, V. Y., Chatterjee, S. S., … & Otto, M. (2012). How Staphylococcus aureus biofilms develop their characteristic structure. Proceedings of the National Academy of Sciences, 109(4), 1281–1286. https://doi.org/10.1073/pnas.1115006109

Lee, K. W. K., Periasamy, S., Mukherjee, M., Xie, C., Kjelleberg, S., & Rice, S. A. (2014). Biofilm development and enhanced stress resistance of a model, mixed-species community biofilm. The ISME Journal, 8(4), 894–907. https://doi.org/10.1038/ismej.2013.194

Periasamy, S., & Kolenbrander, P. E. (2009). Mutualistic biofilm communities develop with Porphyromonas gingivalis and initial, early, and late colonizers of enamel. Journal of Bacteriology, 191(22), 6804–6811. https://doi.org/10.1128/JB.01006-09

Periasamy, S., & Kolenbrander, P. E. (2010). Central role of the early colonizer Veillonella sp. in establishing multispecies biofilm communities with initial, middle, and late colonizers of enamel. Journal of Bacteriology, 192(12), 2965–2972. https://doi.org/10.1128/JB.01631-09

Benedetta Fantaci | Biomedical Engineering | Best Researcher Award

Published on by Scientist Day

Ms. Benedetta Fantaci | Biomedical Engineering | Best Researcher Award

Ms. Benedetta Fantaci | Universidad de Zaragoza | Spain

Dr. Benedetta Fantaci is a distinguished biomedical engineer recognized for her pioneering work in ocular biomechanics and computational modeling. Her research focuses on developing advanced corneal digital twins to enhance precision in laser refractive surgery and deepen understanding of corneal diseases like keratoconus. Through innovative finite-element opto-biomechanical simulations, she bridges the gap between engineering and ophthalmology. Her collaborative projects span several leading European institutions, addressing challenges in eye growth, vascular remodeling, and biomechanical tissue behavior. She has contributed to multiple high-impact publications and served in key scientific and organizational roles at international biomechanics conferences. Her research continues to influence global advances in vision science and biomedical innovation.

Profile: Google Scholar

Featured Publications

Fantaci, B., Calvo, B., & Rodríguez, J. F. (2024). Modeling biological growth of human keratoconus: On the effect of tissue degradation, location and size. Computers in Biology and Medicine, 180, 108976. https://doi.org/10.1016/j.compbiomed.2024.108976

Fantaci, B., Calvo, B., Barraquer, R., Picó, A., & Ariza-Gracia, M. Á. (2024). Establishing standardization guidelines for finite-element optomechanical simulations of refractive laser surgeries: An application to photorefractive keratectomy. Translational Vision Science & Technology, 13(5), 11–11. https://doi.org/10.1167/tvst.13.5.11

Franceschelli, C., & Fantaci, B. (2020). Implementazione di un algoritmo elastostatico inverso con linearizzazione esatta per determinare la geometria vascolare scarica.

Fantaci, B., Calvo, B., Mesa, A. M., & Ortillés, A. (2025). Comparative evaluation of the mechanical properties of amniotic membranes for corneal grafting: Effects of cryopreservation, lyophilization, and dehydration. Journal of the Mechanical Behavior of Biomedical Materials, 107234. https://doi.org/10.1016/j.jmbbm.2025.107234

Fantaci, B., Rodríguez Matas, J. F., Squartecchia, V., Vavassori, L., & Calvo, B. (2025). Unraveling the impact of laser refractive surgery on corneal ectasia: An in silico study. Frontiers in Bioengineering and Biotechnology, 13, 1548539. https://doi.org/10.3389/fbioe.2025.1548539

Azim Paksa | Research Excellence | Best Researcher Award

Published on by Scientist Day

Dr. Azim Paksa | Research Excellence | Best Researcher Award

Dr. Azim Paksa, Shiraz University of Medical Sciences, Iran

Dr. Azim Paksa holds a Ph.D. in Medical Entomology and Vector Control from Tehran University of Medical Sciences, with over 15 years of academic and field experience in vector biology, insecticide resistance, and mosquito ecology. He has led numerous research projects focused on disease vectors such as Anopheles, Aedes, and Blattella germanica, and has published extensively in peer-reviewed ISI and ISC journals. His work includes gene sequencing contributions to GenBank, active participation in national congresses, and involvement in public health initiatives across Iran. Dr. Paksa is a member of the Iranian Societies of Medical Entomology and Parasitology and is skilled in molecular biology techniques, data analysis (SPSS), and scientific publishing.

Author Profile

orcid

🎓 Early Academic Pursuits

Dr. A. Paksa’s academic journey in the field of medical entomology began with a strong foundation at the Tehran University of Medical Sciences, where he pursued and successfully completed a Bachelor’s, Master’s, and Ph.D. in Medical Entomology and Vector Control. His early academic years were marked by a deep interest in public health and vector-borne diseases, which naturally progressed into a lifelong dedication to research and fieldwork. His Master’s thesis focused on detecting resistance mechanisms to organophosphate and carbamate insecticides in Blattella germanica (German cockroach) collected from Tehran hospitals. Later, during his Ph.D., he conducted an extensive study on the genetic diversity, Wolbachia infection, and ecological features of Aedes caspius and Aedes vexans, both of which are significant vectors for arboviruses in Iran. This early research demonstrated his capability in both laboratory and field settings, laying the groundwork for his future contributions to medical entomology and public health.

👨‍🔬 Professional Endeavors

Dr. Paksa has served in multiple academic, research, and public health capacities, working closely with Tehran University of Medical Sciences, Kashan University of Medical Sciences, and Hormozgan University of Medical Sciences, among others. As an executive director and principal collaborator, he has led and completed over a dozen major research projects addressing critical issues in entomology, such as insecticide resistance, vector identification, and ecological surveys of disease-carrying arthropods. In addition to field studies, Dr. Paksa has been an active member of organizing and scientific committees in several national conferences, including the Vector-Borne Diseases and Climate Change Congress and the Iranian National Congress on Medical Entomology, demonstrating his leadership in scientific community engagement.

🧪 Contributions and Research Focus

Dr. Paksa’s contributions to medical entomology are vast and multifaceted. He has authored numerous peer-reviewed ISI and ISC publications, covering topics from mosquito larvicidal properties of essential oils to biochemical resistance mechanisms in disease vectors. His research often combines molecular biology, field ecology, and applied public health, making it both academically rigorous and practically applicable.  His work has been instrumental in identifying and combating insecticide resistance in Anopheles stephensi and Blattella germanica, two vectors of significant public health concern. He has also made critical gene sequence deposits in GenBank, contributing to the global scientific repository with data from Iranian vector species. Dr. Paksa’s dedication to natural product-based insect control is notable—his investigations into the larvicidal effects of Iranian indigenous plant essential oils have opened new avenues in eco-friendly vector control strategies.

🏆 Accolades and Recognition

Throughout his career, Dr. Paksa has earned recognition for both the quality and breadth of his research. His presence in multiple national scientific conferences, both as a presenter and an organizing committee member, speaks to the high regard in which he is held by peers. He has served as a referee for the Journal of Arthropod-Borne Diseases and evaluated proposals and books for Zabol University of Medical Sciences, further reflecting his expertise and trustworthiness in scientific evaluation. Moreover, his active membership in the Iranian Society of Medical Entomology and Medical Parasitology for over a decade underscores his commitment to scientific collaboration and advancement within his specialty.

🌍 Impact and Influence

Dr. Paksa’s research has had a direct impact on vector control policies, hospital hygiene practices, and disease prevention strategies in Iran. His work on cockroach and mosquito resistance mechanisms has influenced how hospitals and municipalities approach pest control. Furthermore, his studies on head lice prevalence in schoolchildren and tick infestation in livestock have provided critical insights into zoonotic disease transmission and public health education. By combining field data with molecular insights, Dr. Paksa bridges the gap between lab-based science and real-world applications—making his work especially valuable to policy-makers, healthcare providers, and environmental health professionals.

🔬 Legacy and Future Contributions

With a solid foundation built on two decades of field experience, scientific research, and public health collaboration, Dr. Paksa is well-positioned to continue making influential contributions in the years ahead. His current projects focus on the molecular mechanisms of resistance in vector populations and the development of environmentally sustainable vector control strategies. In the future, Dr. Paksa aims to deepen international collaborations, contribute to global malaria and arboviral control efforts, and mentor the next generation of entomologists in Iran and beyond. His legacy will likely be remembered not only for his extensive publication record and field innovations but also for his dedication to improving public health through evidence-based research.

✍️Notable Publications

Molecular assay on detection of crimean congo hemorrhagic fever (CCHF) virus in ixodid ticks collected from livestock in slaughterhouse from south of Iran

Contributors: Salehi-Vaziri, M.; Vatandoost, H.; Sanei-Dehkordi, A.; Fazlalipour, M.; Pouriayevali, M.H.; Jalali, T.; Mohammadi, T.; Tavakoli, M.; Paksa, A.; Abadi, Y.S.

Journal: Arthropod-Borne Diseases

Year:2020

Biodiversity of mosquitoes (Diptera: Culicidae) with emphasis on potential arbovirus vectors in East Azerbaijan province, northwestern Iran

Contributors: Paksa, A.; Sedaghat, M.M.; Vatandoost, H.; Yaghoobi-Ershadi, M.R.; Moosa-Kazemi, S.H.; Hazratian, T.; Sanei-Dehkordi, A.; Oshaghi, M.A.

Journal: Arthropod-Borne Diseases

Year: 2019

Wild chive oil is an extremely effective larvicide against malaria mosquito vector Anopheles stephensi

Contributors: Sanei-Dehkordi, A.; Soleimani-Ahmadi, M.; Abadi, Y.S.; Paksa, A.
Journal: Tropical Medicine
Year: 2019

Haishan Jiang | Medical Discoveries | Innovation in Science Award

Published on by Scientist Day

Dr. Haishan Jiang | Medical Discoveries | Innovation in Science Award 

Dr. Haishan Jiang, Southern Medical University, China

Dr. Haishan Jiang, Chief Physician and Associate Professor at Southern Medical University’s Nanfang Hospital, is a leading expert in neurology, specializing in myopathy, peripheral neuropathy, and rare neurological diseases. As Deputy Director of the Neurology Department and head of the Myopathy and Peripheral Neuropathy subspecialty, he has pioneered gene therapies for SMA and ALS in South China. His research focuses on motor neuron and mitochondrial diseases, as well as gene therapy for rare conditions. Widely recognized, Dr. Jiang has been honored as the “Good Doctor of Guangzhou” and ranks top nationally in physician recommendations for multiple rare diseases.

Author Profile

ORCID

🧑‍🎓 Early Academic Pursuits

Dr. Haishan Jiang embarked on his medical journey with a deep-rooted commitment to understanding the complexities of the human nervous system. With a Doctor of Medicine degree and solid academic grounding, he demonstrated early on a keen interest in neurology, particularly in the areas of myopathy and peripheral neuropathy. His academic path was marked by diligence, a sharp scientific mind, and a profound dedication to uncovering the underlying mechanisms of rare neurological diseases. As a postgraduate supervisor, Dr. Jiang has also shown a strong passion for nurturing the next generation of medical professionals, sharing his knowledge and guiding their research pursuits with patience and precision.

🩺 Professional Endeavors

Currently serving at Nanfang Hospital of Southern Medical University, Dr. Jiang holds several key positions: Chief Physician, Associate Professor, Deputy Director of the Neurology Department, Director of Teaching, and Head of the Myopathy and Peripheral Neuropathy subspecialty. His clinical expertise spans a wide spectrum of neurological disorders, with a particular emphasis on difficult and rare conditions such as motor neuron disease (ALS), mitochondrial encephalomyopathy, and adult-onset spinal muscular atrophy (SMA). Dr. Jiang’s commitment to clinical excellence has led him to establish and lead the Guangdong Province Myopathy and Peripheral Nerve Specialized Alliance, a network aimed at advancing diagnosis, treatment, and research collaboration. Under his leadership, the department ranks among the top two nationally in terms of annual muscle and nerve biopsy volume, solidifying its reputation as a hub for neuromuscular disease care.

🧬 Contributions and Research Focus

Dr. Jiang’s research interests are firmly rooted in neurogenetic disorders, particularly motor neuron diseases (ALS) and mitochondrial disorders. His work seamlessly blends basic science with clinical application, focusing on understanding disease mechanisms and exploring cutting-edge gene therapy approaches. He has spearheaded some of South China’s most advanced gene therapy trials, including the region’s first gene therapy for adult SMA—the fourth such case in the country—and the first ALS gene therapy clinical trial in South China, also the second nationwide. His pioneering research not only contributes to academic knowledge but also offers hope to patients battling previously untreatable conditions. Through his clinical studies, Dr. Jiang is pushing the frontiers of personalized medicine, bringing precision diagnostics and therapy into the mainstream for rare and complex neurological diseases.

🏅 Accolades and Recognition

Dr. Haishan Jiang’s unwavering dedication to medical science and patient care has earned him widespread acclaim. Notably, he was honored as the sixth “Good Doctor of Guangzhou” and selected as part of the ninth batch of “Outstanding Provincial and Municipal Talents Supporting Xinjiang”, a testament to both his clinical excellence and humanitarian spirit. Furthermore, he was recognized by the Good Doctor Network as an “Annual Good Doctor” for his exceptional service in rare disease diagnosis and treatment. His reputation as a leading clinician is reflected in his top rankings in national physician recommendation lists—first place for 13 diseases, including ALS and mitochondrial encephalomyopathy, and second place for 15 others. These accolades not only highlight his expertise but also the trust he has earned from patients and peers alike.

🌍 Impact and Influence

Dr. Jiang’s work has had a transformative impact on neurology in China, particularly in the realm of rare diseases. By advancing the use of gene therapy and establishing regional alliances, he has created a robust infrastructure for collaboration, research, and clinical care. His contributions have significantly improved diagnostic timelines and therapeutic options for patients who previously faced long diagnostic odysseys and limited treatment possibilities. As a teacher and mentor, Dr. Jiang has shaped the careers of countless postgraduate students and young doctors, many of whom now contribute to clinical neurology and research across the country. His influence extends beyond the clinic to policy and advocacy, where he is a strong voice for the rare disease community.

🔬 Legacy and Future Contributions

Dr. Haishan Jiang stands at the forefront of a new era in neurology, where genomics and personalized medicine are reshaping how we understand and treat complex diseases. His legacy is already evident in the systems he has built, the patients he has helped, and the students he has inspired. Looking ahead, Dr. Jiang aims to further expand gene therapy applications, develop innovative treatment protocols, and foster international collaboration in rare disease research. With his continued focus on combining scientific rigor with compassionate care, Dr. Jiang is set to leave a lasting legacy in Chinese and global neurology. His work is not only rewriting the medical narrative for patients with rare conditions but also paving the way for future breakthroughs in neuroscience.

✍️ Publication Top Notes

📘A Multicenter Study of Hereditary Transthyretin Amyloidosis in China

Author: Xujun Chu; Juan Kang; Jingwen Xu; Haishan Jiang; Zhi‐Ying Wu; Qingping Wang; Wei Li; Jia Li;
Journal: Annals of Neurology
Year:2025

📘Knockdown of OPTN modulates miRNA-125b-5p expression via NF-κB pathways in amyotrophic lateral sclerosis

Author: Jian Qin; Ye He; Weiyi Yu; Zhaoyong Zhang; Xiaodan Chen; Yafang Hu; Haishan Jiang
Journal: Archives of Biochemistry and Biophysics
Year: 2025

📘Clinical features of hereditary transthyretin amyloidosis-polyneuropathy with transthyretin Ala97Ser(p.Ala117Ser) mutation in South Mainland China

Author: Yeli Zhu; Jingxian Fan; Xiying Zhu; Wei Li; Zhaoyong Zhang; Hui Zheng; Zhihua Zhou; Lingchao Meng; Ruxu Zhang; Haishan Jiang
Journal: Orphanet Journal of Rare Diseases
Year: 2025